Back to PTCT

CITADEL ADVISORS LLC → PTCT

CITADEL ADVISORS LLC PTCT Position History

PTC Therapeutics, Inc. • Healthcare

Quarters held
16
Latest value
$2.9M
Q3 2026
Peak value
$40.7M
First seen
Q1 2026

Dollar value over time

Show data table
PeriodPosition value
Q1 2026$10.5M
Q1 2026$1.2M
Q1 2026$15.8M
Q1 2026$743K
Q2 2026$20.3M
Q2 2026$530K
Q2 2026$40.7M
Q2 2026$1M
Q2 2026$20.3M
Q2 2026$530K
Q2 2026$40.7M
Q2 2026$1M
Q3 2026$20.6M
Q3 2026$952K
Q3 2026$7.1M
Q3 2026$2.9M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$2.9M45.1K——
Q3 2026$7.1M110.0K——
Q3 2026$952K14.7K——
Q3 2026$20.6M317.2K——
Q2 2026$1M12.5K——
Q2 2026$40.7M498.5K——
Q2 2026$530K6.5K——
Q2 2026$20.3M249.3K——
Q2 2026$1M12.5K——
Q2 2026$40.7M498.5K——
Q2 2026$530K6.5K——
Q2 2026$20.3M249.3K——
Q1 2026$743K10.9K——
Q1 2026$15.8M231.2K——
Q1 2026$1.2M17.4K——
Q1 2026$10.5M154.0K——

Other funds holding PTCT

Other CITADEL ADVISORS LLC positions

ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$11.2B
SPY

SPDR S&P 500 ETF TR

$3B
MSFT

MICROSOFT CORP

$2.9B
ETHA

ISHARES TR

$2.7B
SPY

SPDR S&P 500 ETF TR

$2.6B
SPY

STATE STR SPDR S&P 500 ETF T

$2.4B